Covered recipient · General Payments record
NIRAV K SHAH
General Payments · PY2018–2024
$13,548.93
- Reported across 156 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $898.43 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Nevro Corp. | $328.42 | 3 |
| GlaxoSmithKline, LLC. | $162.94 | 5 |
| Medtronic, Inc. | $133.30 | 2 |
| GENZYME CORPORATION | $104.58 | 1 |
| Electronic Waveform Lab, Inc. | $65.79 | 1 |
| Dilon Technologies, Inc. | $49.67 | 1 |
| Stryker Corporation | $28.75 | 1 |
| Abbott Laboratories | $24.98 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.98 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125083337 | CMS |
| Dilon Technologies, Inc. | $49.67 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112840655 | CMS |
| Electronic Waveform Lab, Inc. | $65.79 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089551669 | CMS |
| GENZYME CORPORATION | $104.58 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139789395 | CMS |
| GlaxoSmithKline, LLC. | $19.14 | 02/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116584453 | CMS |
| GlaxoSmithKline, LLC. | $3.65 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116155883 | CMS |
| GlaxoSmithKline, LLC. | $11.03 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116659149 | CMS |
| GlaxoSmithKline, LLC. | $9.42 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115992230 | CMS |
| GlaxoSmithKline, LLC. | $119.70 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115807513 | CMS |
| Medtronic, Inc. | $23.98 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119335111 | CMS |
| Medtronic, Inc. | $109.32 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119335113 | CMS |
| Nevro Corp. | $94.40 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130785782 | CMS |
| Nevro Corp. | $107.00 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130785784 | CMS |
| Nevro Corp. | $127.02 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130785786 | CMS |
| Stryker Corporation | $28.75 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119976619 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.